English version
Marianne Kristiansen Kringen

Marianne Kristiansen Kringen

Forskningsprosjekter

Vitenskapelige publikasjoner

Muriel, J.; Escorial, M.; Carratalá, C.; Margarit, C.; Barrachina, J.; López, A.; Gallardo, E.; Kringen, Marianne K. ; Peiró, A.M. (2024). Use of CYP2D6 substrates and inhibitors during pain management with analgesic opioids: Drug-drug interactions that lead to lack of analgesic effectiveness. Biomedicine & Pharmacotherapy. Vol. 176.
https://doi.org/10.1016/j.biopha.2024.116882

Chalabianloo, Fatemeh; Fadnes, Lars T.; Johansson, Kjell Arne; Høiseth, Gudrun; Vold, Jørn Henrik; Kringen, Marianne K. ; Spigset, Olav; Bramness, Jørgen Gustav (2024). Methadone pharmacokinetics in opioid agonist treatment: Influencing factors and clinical implications. Basic & Clinical Pharmacology & Toxicology. Vol. 134.
https://doi.org/10.1111/bcpt.13975

Smith, Robert Løvsletten; Wollmann, Birgit Malene Tovik; Størset, Elisabet; Lenk, Hasan Çağın; O'Connell, Kevin S.; Kringen, Marianne K. ; Ingelman-Sundberg, Magnus; Molden, Espen (2024). Effect of the NFIB rs28379954 T>C polymorphism on CYP2D6-catalyzed metabolism of solanidine. Clinical and Translational Science (CTS). Vol. 17.
https://doi.org/10.1111/cts.13743

Hovd, Markus Herberg; Robertsen, Ida; Johnson, Line Kristin; Krogstad, Veronica; Wegler, Christine; Kvitne, Kine Eide; Kringen, Marianne K. ; Skovlund, Eva; Karlsson, Cecilia; Andersson, Shalini; Artursson, Per; Sandbu, Rune; Hjelmesæth, Jøran Sture; Åsberg, Anders; Jansson-Löfmark, Rasmus; Christensen, Hege (2023). Neither Gastric Bypass Surgery Nor Diet-Induced Weight-Loss Affect OATP1B1 Activity as Measured by Rosuvastatin Oral Clearance. Clinical Pharmacokinetics. Vol. 62.
https://doi.org/10.1007/s40262-023-01235-5

Wollmann, Birgit Malene Tovik; Størset, Elisabet; Kringen, Marianne K. ; Molden, Espen; Smith, Robert Løvsletten (2023). Prediction of CYP2D6 poor metabolizers by measurements of solanidine and metabolites—a study in 839 patients with known CYP2D6 genotype. 8 s. European Journal of Clinical Pharmacology. Vol. 79.
https://doi.org/10.1007/s00228-023-03462-y

Wollmann, Birgit Malene Tovik; Smith, Robert Løvsletten; Kringen, Marianne K. ; Ingelman-Sundberg, Magnus; Molden, Espen; Størset, Elisabet (2023). Evidence for solanidine as a dietary CYP2D6 biomarker: Significant correlation with risperidone metabolism. British Journal of Clinical Pharmacology.
https://doi.org/10.1111/bcp.15721

Solhaug, Vigdis; Haslemo, Tore ; Kringen, Marianne Kristiansen ; Molden, Espen; Dietrichs, Erik Sveberg (2022). Genotyping av pasienter behandlet med selektive serotoninreopptakshemmere. 9 s. Tidsskrift for Den norske legeforening. Vol. 142.
https://doi.org/10.4045/tidsskr.22.0017

Chalabianloo, Fatemeh; Høiseth, Gudrun; Vold, Jørn Henrik; Johansson, Kjell Arne; Kringen, Marianne K. ; Dalgard, Olav; Ohldieck, Christian; Druckrey-Fiskaaen, Karl Trygve; Aas, Christer Frode; Løberg, Else-Marie; Bramness, Jørgen Gustav; Fadnes, Lars T. (2022). Impact of liver fibrosis and clinical characteristics on dose-adjusted serum methadone concentrations. 11 s. Journal of Addictive Diseases. Vol. 41.
https://doi.org/10.1080/10550887.2022.2057140

Smith, Robert Løvsletten; Wollmann, Birgit Malene Tovik; Kausberg, Marianne; Mæland, Sondre; Tveito, Marit; O'Connell, Kevin Sean; Molden, Espen; Kringen, Marianne K. (2022). Effects of a Novel UGT2B Haplotype and UGT1A4*3 Allele Variants on Glucuronidation of Clozapine In vivo. 6 s. Current drug metabolism. Vol. 23.
https://doi.org/10.2174/1389200223666220201152953

Lenk, Hasan Cagin; Smith, Robert Løvsletten; O'Connell, Kevin Sean; Jukić, Marin M.; Kringen, Marianne K. ; Andreassen, Ole; Ingelman-Sundberg, Magnus; Molden, Espen (2022). Impact of NFIB and CYP1A variants on clozapine serum concentration—A retrospective naturalistic cohort study on 526 patients with known smoking habits. Clinical and Translational Science (CTS).
https://doi.org/10.1111/cts.13422





Publikasjonslisten er hentet ut av Cristin. Listen kan være ufullstendig